ES2067461T3 - Derivados isoprenoides y agentes anti-ulcerosos que contienen los mismos. - Google Patents

Derivados isoprenoides y agentes anti-ulcerosos que contienen los mismos.

Info

Publication number
ES2067461T3
ES2067461T3 ES88113617T ES88113617T ES2067461T3 ES 2067461 T3 ES2067461 T3 ES 2067461T3 ES 88113617 T ES88113617 T ES 88113617T ES 88113617 T ES88113617 T ES 88113617T ES 2067461 T3 ES2067461 T3 ES 2067461T3
Authority
ES
Spain
Prior art keywords
ulcerous
agents containing
isoprenoid derivatives
derivatives
isoprenoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88113617T
Other languages
English (en)
Inventor
Kazuhiko Yamada
Yoshiyuki Tahara
Masashi Toyoda
Osamu Irino
Noriyuki Misaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Seifun Group Inc
Aska Pharmaceutical Co Ltd
Original Assignee
Grelan Pharmaceutical Co Ltd
Nisshin Seifun Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grelan Pharmaceutical Co Ltd, Nisshin Seifun Group Inc filed Critical Grelan Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2067461T3 publication Critical patent/ES2067461T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/215—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring having unsaturation outside the six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/18—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring
    • C07C39/19—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring containing carbon-to-carbon double bonds but no carbon-to-carbon triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/02—Quinones with monocyclic quinoid structure
    • C07C50/06—Quinones with monocyclic quinoid structure with unsaturation outside the quinoid structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

SE SUMINISTRAN AGENTES ANTIULCERA QUE CONTIENEN DERIVADOS ISOPRENOIDES. LOS DERIVADOS ISOPRENOIDES ESTAN REPRESENTADOS POR LA FORMULA 1 EN LA CUAL R REPRESENTA UN GRUPO DE FORMULA.
ES88113617T 1987-08-25 1988-08-22 Derivados isoprenoides y agentes anti-ulcerosos que contienen los mismos. Expired - Lifetime ES2067461T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20921487 1987-08-25
JP9677088 1988-04-21

Publications (1)

Publication Number Publication Date
ES2067461T3 true ES2067461T3 (es) 1995-04-01

Family

ID=26437948

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88113617T Expired - Lifetime ES2067461T3 (es) 1987-08-25 1988-08-22 Derivados isoprenoides y agentes anti-ulcerosos que contienen los mismos.

Country Status (6)

Country Link
US (1) US4906669A (es)
EP (1) EP0304842B1 (es)
JP (1) JP2708126B2 (es)
KR (1) KR970001518B1 (es)
DE (1) DE3852245T2 (es)
ES (1) ES2067461T3 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07504887A (ja) * 1991-11-22 1995-06-01 リポジェニックス，インコーポレイテッド トコトリエノールおよびトコトリエノール様化合物ならびにこれらを使用する方法
US6187811B1 (en) 1998-10-28 2001-02-13 Lipogenics, Inc. Methods for treating benign prostatic hyperplasia using tocotrienols
RU2411229C2 (ru) * 2004-09-23 2011-02-10 Учреждение Российской академии наук Тихоокеанский институт биоорганической химии Дальневосточного отделения РАН (ТИБОХ ДВО РАН) Терапевтические хиноны

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1147612A (en) * 1965-04-07 1969-04-02 Takeda Chemical Industries Ltd Compositions for the treatment of peptic ulcers
US3875163A (en) * 1972-02-29 1975-04-01 Pierrel Spa Nitrogen containing acyclic isoprenoid compounds
CH593224A5 (es) * 1973-10-30 1977-11-30 Taisho Pharmaceutical Co Ltd
BE810299A (fr) * 1974-01-29 1974-05-16 Procede de fabrication de composes contenant un noyau chromane.
FR2259822A1 (en) * 1974-02-06 1975-08-29 Teijin Ltd Cpds. contg. chroman rings - from hydroquinones and carboxylic acid derivs in the presence of an insol solid acid catalyst
FR2314722A1 (fr) * 1975-06-19 1977-01-14 Etud Expl Marques Brevets Procede de preparation d'acetylsalicylate de tocol et homologues
JPS5619049A (en) * 1979-07-25 1981-02-23 Konishiroku Photo Ind Co Ltd Silver halide photographic material
US4393075A (en) * 1980-04-14 1983-07-12 Takeda Chemical Industries, Ltd. Quinone compounds and their use in suppressing the production of SRS-A in mammals
FR2504004A1 (fr) * 1981-04-17 1982-10-22 Roussel Uclaf Application a titre de medicaments de derives d'acides phenyl aliphatique carboxyliques
US4617317A (en) * 1984-10-31 1986-10-14 Bennet Justin D Method of treating ulcerative colitis
JPS61210030A (ja) * 1985-03-13 1986-09-18 Agency Of Ind Science & Technol 抗腫瘍剤

Also Published As

Publication number Publication date
DE3852245D1 (de) 1995-01-12
EP0304842A2 (en) 1989-03-01
KR890003389A (ko) 1989-04-14
KR970001518B1 (ko) 1997-02-11
EP0304842A3 (en) 1991-01-16
DE3852245T2 (de) 1995-04-20
JP2708126B2 (ja) 1998-02-04
JPH0242030A (ja) 1990-02-13
US4906669A (en) 1990-03-06
EP0304842B1 (en) 1994-11-30

Similar Documents

Publication Publication Date Title
ES2063036T3 (es) Compuestos (aralquil-sustituido) heterociclicos.
DK172089D0 (da) 1,3-dioxolanderivater samt fremgangsmaade til fremstilling deraf
ES2017611T3 (es) Tiazoles sustituidos y su uso como fungicidas.
LV5742A4 (lv) 3,5-Divaizvietoti pirokatehina atvasinajumi
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
NO870437D0 (no) Cykloalkanol(1.2-6)indol-sulfonamider.
ES2058069T3 (es) Derivados de 5h-1,3,4-tiadiazolo-(3,2-a)-pirimidin-5-ona y nuevo compuesto fungicida agricola-horticola que contiene dicho derivado.
DE3782999D1 (de) Bohrloch-zementierungszusammensetzungen.
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
IT1208460B (it) Derivati benzimidazolici utili come agenti antiulcera
FI870492A7 (fi) Vaermevaexlare och saett att framstaella en saodan
DK633588D0 (da) Aminderivater
DE3861251D1 (de) Negative resistzusammensetzungen.
DE3684244D1 (de) Flavon-derivate.
AR241022A2 (es) "fosfatidos de eteres de glicerina y procedimiento para su preparacion"
ES2119874T3 (es) Nuevos derivados de elipticina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
NO165701C (no) Innlegg for soeppelboks.
ES2008109B3 (es) Procedimiento de preparacion de aminoalcoholes y de composiciones farmaceuticas que los contienen.
DK382788D0 (da) 4-amino-substituerede 1,2-dihydroxy-naphthalen-derivater
ES2067461T3 (es) Derivados isoprenoides y agentes anti-ulcerosos que contienen los mismos.
ES2042726T3 (es) Beta-alquilmelatoninas.
DE3855121D1 (de) Anxiolytisch wirksame Piperazinderivate
ES2062170T3 (es) Composiciones de tinta con base agua.
BG38337A3 (en) Method for preparing 6 alpha- methylhydrocortisonic derivatives
DE3779991D1 (de) Dioxopiperidin-derivate enthaltende anxiolytische zusammensetzungen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 304842

Country of ref document: ES